What does TruBridge do and what are its main business segments?

Did TruBridge beat or miss consensus estimates last quarter?

What guidance did TruBridge's management provide for the next earnings period?

What is TruBridge's latest dividend and current dividend yield?

What is the revenue and EPS growth rate for TruBridge year over year?

What is the market's earnings forecast for TruBridge next quarter?

What is TruBridge's gross profit margin?

What were the key takeaways from TruBridge’s earnings call?

- **Revenue and Profit Growth**: Full-year revenue +1.4% YoY to $346.8M, Adjusted EBITDA +23% YoY to $68.7M. Free cash flow $20M (+25% YoY). 
- **Pipeline Strength**: Bookings $82.9M (+1% YoY), Q4 bookings $19.8M (+37% YoY). Pipeline up 53% since Q3, 70% recurring deals. 
- **AI-Driven Efficiency**: Ambient Technology pilot reduces documentation time 50-75%. Target 200bps EBITDA margin expansion in 2026. 
- **Financial Health**: Net leverage 2x, $24.9M cash. Amended credit agreement provides $250M facilities. 
- **Strategic Focus**: Global workforce transition, encoder growth, and AI investments driving margin expansion. Rural Health Care Fund presents $50B opportunity.

**【CEO Summary Section】**
- **Revenue and Profit Growth**: Full-year revenue reached $346.8 million (+1.4% YoY), with Adjusted EBITDA of $68.7 million (+23% YoY). Q4 revenue was $87.2 million, in line with revised guidance, and Adjusted EBITDA was $19.2 million (high end of guidance range). Free cash flow for the year was $20 million (+25% YoY). 
- **Pipeline and Bookings Momentum**: Total bookings of $82.9 million (+1% YoY) on TCV basis, with Q4 bookings at $19.8 million (+31% QoQ, +37% YoY). Pipeline grew 53% since Q3, with 70% of opportunities recurring vs. 57% last summer. Encoder pipeline increased 74%.
- **Customer Retention and AI Strategy**: Implemented structured transition model to improve retention in CBO customers. AI initiatives across 4 pillars (financial health, patient care, customer service, internal dev) driving efficiency. Ambient Technology pilot reduced documentation time by 50-75%.
- **Strategic Review**: Not providing formal 2026 guidance, but targeting modest revenue growth and 200bps EBITDA margin expansion. Global Capacity Center in Chennai operational.

**【CFO Financial Commentary】**
- **Cash Flow and Debt Management**: Cash flow from operations $37 million (+19% YoY). Reduced net debt by $19.5 million to $139.8 million, with net leverage ratio at 2x. Free cash flow $20 million (+25% YoY). 
- **Margin Expansion**: Adjusted EBITDA margin expanded 350bps YoY to 20%, driven by cost optimization (IT, cloud, patient care support). Gross margin 53% (flat YoY, +120bps QoQ). 
- **Balance Sheet Strength**: $24.9 million cash on hand. Amended credit agreement provides $250 million facilities at attractive rates. 
- **2026 Outlook**: Target 200bps EBITDA margin expansion through global workforce transition, cost optimization, and higher-margin encoder solutions.

**【Q&A Key Highlights】**
- **Bookings Conversion**: Recurring revenue baseline + attrition assumptions needed for modeling. 2026 renewals similar to 2025 levels. 
- **Customer Retention**: Q4 retention improving but still impacted by global workforce transition. 2026 bookings growth driven by pipeline conversion. 
- **AI Impact**: Ambient Technology pilot at 50%+ documentation time reduction. AI-driven support bot improving customer self-service efficiency. 
- **Strategic Review**: No timeline for decision; Board focused on maximizing shareholder value. 
- **Partnerships**: RevSpring partnership to enhance patient collections; impact expected in 2027. 
- **Regulatory Environment**: Rural Health Care Fund ($50B) presents opportunity for EHR/RCM solutions; state-specific strategies being developed.

TruBridge, Inc. (TBRG) Q4 2025 Earnings Call Transcript

- **Revenue Resilience**: Q3 2025 revenue grew 2% YoY to $86.1 million, with 94% recurring revenue.
- **Bookings Quality Focus**: Q3 bookings of $15.5 million underperformed but reflected strategic shift to high-margin Encoder deals (+100% YoY bookings growth).
- **Margin Expansion Roadmap**: 2026 EBITDA margin expansion of 200+ basis points expected from cost savings ($35M debt reduction since Q1 2024) and offshore transitions.
- **Sales Leadership Impact**: New CBO Mike Daughton is reorganizing sales to target 100-400-bed hospitals, where Financial Health bookings have grown to 30% of total (vs. <20% in 2024).
- **Operational Efficiency**: Capitalized software spend down 30% YoY, and free cash flow improved $20M year-to-date 2025.

**【CEO Summary Section】**
- **Revenue Growth**: Total revenue for Q3 2025 was $86.1 million, up 2% year-over-year (2.8% excluding the sunset of the Centriq product). Recurring revenue represented 94% of total revenue.
- **Bookings Performance**: Q3 bookings were $15.5 million (TCV), under expectations but focused on higher-margin deals. October bookings exceeded historical trends, signaling potential pipeline conversion acceleration.
- **Strategic Initiatives**: 
  - **Offshore Transition**: Resumed with 2 customer transitions in Q4, targeting 200+ basis points of EBITDA margin expansion by 2026 through cost savings and improved client retention.
  - **Sales Leadership**: Mike Daughton, new Chief Business Officer, is restructuring sales, marketing, and client success to enhance pipeline quality and conversion.
  - **Encoder Growth**: Year-to-date Encoder bookings doubled, contributing 70-80% margins.

**【CFO Financial Commentary】**
- **Profitability**: Adjusted EBITDA margin for Q3 was 18.9% ($16.3 million), up 155 basis points year-over-year. Full-year 2025 guidance for adjusted EBITDA is $65-68 million (19% margin), with 2026 targeting 200+ basis points of further expansion.
- **Cash Flow & Debt**: Free cash flow year-to-date 2025 was $15 million (vs. -$5 million in 2023). Net debt reduced by $35 million since Q1 2024 to $144 million, with leverage ratio improving to 2.2x.
- **Cost Optimization**: Capitalized software spend decreased 30% YoY to $12.5 million, and operating expenses were flat at $40 million (46% of revenue).

**【Q&A Key Highlights】**
- **Pipeline & Bookings Quality**: Q3 bookings underperformed by ~20%, but October bookings indicate delayed decisions are resolving. Focus on high-margin Encoder and SaaS conversions is driving 30%+ growth in 100-400-bed Financial Health bookings.
- **Margin Expansion Drivers**: 
  - **Cost Control**: 2026 EBITDA margin expansion of 200+ basis points expected from continued cost optimization and offshore transitions.
  - **Revenue Mix**: Higher-margin Encoder and SaaS bookings (e.g., 60% gross margin in Patient Care) are improving overall profitability.
  - **Client Retention**: Net retention rate improving in Q3, with renewed focus on client success and transition process transparency.
- **Regulatory Impact**: Medicaid funding uncertainty is delaying some decisions, but the rural hospital funding bill (OBBB) is expected to create tailwinds for 2026 RCM investments.

TruBridge, Inc. (TBRG) Q3 2025 Earnings Call Transcript

- **Revenue Growth & Margin Expansion**: Q2 bookings up 10% YoY, EBITDA margin 16% (vs. 15.7% YoY). FY25 EBITDA guidance raised to 18.5% midpoint.
- **India Strategy**: Physical office in 2026 to drive 2026+ growth through standardized workflows and productivity improvements.
- **AI Innovation**: Microsoft Copilot integration for EHR, AI-driven client support tools enhance efficiency and client experience.
- **Client Retention Focus**: 21/26 CBO renewals YTD; India office and resource management to improve retention in 2026.
- **Debt Reduction**: 2.4x net leverage (vs. 3.9x YoY), $32.5M debt paid since Jan 2024.


**【CEO Summary Section】**
- **CMS Interoperability Pledge**: Signed at the White House, emphasizing commitment to rural healthcare through modern data infrastructure and AI-driven solutions.
- **Q2 Financials**: Bookings of $25.6M (10% YoY growth), revenue $85.7M (flat YoY), adjusted EBITDA $13.7M (16% margin). Revised FY25 guidance: Revenue $345-350M, EBITDA $62-67M (up 200bps YoY).
- **Client Retention Challenges**: CBO renewals at 21/26 year-to-date, with plans to improve through resource management, India office (2026), and leadership hires.
- **Strategic Initiatives**: 
  - **India Expansion**: Physical office to standardize workflows, enhance productivity, and support 2026+ growth.
  - **AI Integration**: Microsoft Copilot for EHR, AI-driven client support tools for efficiency.
  - **Encoder Growth**: 13% QoQ bookings, higher gross margins driving profitability.

**【CFO Financial Commentary】**
- **Cash Flow**: $14.5M YoY increase in operating cash flow, free cash flow $5.5M (up 200% YoY).
- **Debt Reduction**: 2.4x net leverage (down from 3.9x YoY), $32.5M debt paid since Jan 2024.
- **Margins**: Gross margin 52% (up 250bps YoY), Financial Health 46% (up 150bps YoY), Patient Care 62% (up 400bps YoY).
- **Cost Efficiency**: $1M+ savings from resource management, India office, and encoder mix shift.

**【Q&A Highlights】**
- **Savings Pacing**: Client support modernization to yield low-single-digit million savings Q4+; mid-20s EBITDA margin target by 2026.
- **OB3 Impact**: Clients planning for Medicaid eligibility changes; potential 2025H2 headwinds, long-term opportunity for TruBridge.
- **Retention Trends**: Patient Care retention >95%; Financial Health CBO renewals improving sequentially, Encoder bookings up 13% QoQ.
- **Viewgol Integration**: Captive model benefits offset by implementation complexity; India office to accelerate offshore adoption in 2026.
- **Attrition Insights**: 70%+ attrition due to in-sourcing; relationship-driven recovery strategy with U.S.-based account teams.


TruBridge, Inc. (TBRG) Q2 2025 Earnings Call Transcript

- **Revenue Beat**: Q1 2025 revenue of $87 million (+3.7% YoY) exceeded expectations, driven by 5% growth in Financial Health core business.
- **Booking Strength**: $22 million Q1 bookings (ACV $17.3 million) included two strategic 100-400-bed hospital wins, up 50% sequentially in Financial Health.
- **Leverage Reduction**: Net debt/EBITDA improved to 2.4x vs. 4.4x a year ago, with $26 million debt repayment since Q1 2024.
- **Automation Savings**: Mid-single-digit million cost savings expected from offshore workforce transition and AI adoption in 2025.
- **Customer Resilience**: 98% Patient Care retention rate; hospitals prioritize revenue cycle management despite macro uncertainty.


**【CEO Summary Section】**
- **Revenue Growth**: Q1 2025 revenue of $87 million exceeded guidance, up 3.7% YoY (6.5% adjusted for divestitures). Financial Health revenue grew 5%, driven by core CBO business expansion.
- **Bookings Momentum**: Q1 bookings totaled $22 million (ACV $17.3 million), with 50% sequential growth in Financial Health and 60% in Patient Care. Notable wins included two 100-400-bed hospital deals via land-and-expand strategy.
- **Operational Initiatives**: 
  - Global workforce transition: 30% of CBO clients now offshore, targeting 60% by end-2025.
  - Automation investment: AI-driven RCM workflow automation to enhance efficiency.
  - Customer retention: 98% Patient Care retention rate, 9/11 renewals in Financial Health pipeline.
- **Policy Impact**: Hospitals cautious on capital allocation amid healthcare funding uncertainty, but core need for revenue cycle management remains strong.

**【CFO Financial Commentary】**
- **Profitability**: Adjusted EBITDA of $18.2 million (20.9% margin) up 860bps YoY, driven by revenue growth and $2 million timing benefits.
- **Cash Flow**: Operating cash flow improved $7.4 million YoY to $5.4 million; net leverage ratio reduced to 2.4x from 4.4x a year ago.
- **Guidance Update**: Full-year 2025 revenue $345-360 million, EBITDA $60-66 million (up from $59-66 million). Q2 revenue expected to decline due to $3 million conference costs and $1 million revenue timing shifts.
- **Cost Optimization**: $3 million debt repayment in Q1, total $26 million since Q1 2024. Offshore transition expected to deliver mid-single-digit million savings in 2025.

**【Q&A Highlights】**
- **Policy Risks**: Tariffs and healthcare funding uncertainty causing customer caution, but revenue cycle management remains critical. No direct tariff impact on TruBridge operations.
- **Automation Progress**: Early-stage AI adoption in RCM workflows, with focus on standardizing processes for scalability.
- **Retention Outlook**: 98% Patient Care retention rate stable; Financial Health renewals tracking to plan despite macro uncertainty.
- **SaaS Transition**: Patient Care bookings increasingly recurring (90%+ new deals), reducing one-time implementation revenue volatility.


TruBridge, Inc. (TBRG) Q1 2025 Earnings Call Transcript

- **2024 Strong Finish**: Q4 revenue $87.4M (+2% YoY), EBITDA $17.2M (+44% YoY). Full-year EBITDA $53M (+12% YoY), cash flow $32M vs. $1M in 2023.
- **Global Workforce Payoff**: 30% of CBO clients onshore, targeting 60% in 2025. Q4 gross margin 53% (vs. 44.7% in 2023), driven by $6M cost savings.
- **nTrust Growth Engine**: 24 deals in 2024 (vs. 18 in 2023). 75% of lost deals due to "no decision" vs. competition.
- **2025 Guidance**: 4% revenue growth, EBITDA $59-66M. 60 key CBO renewals over 24 months, 1/3 EHR customers to SaaS.
- **Risk Management**: 3x leverage ratio (down from 4x). 2025 free cash flow target 29% of EBITDA.
- **Key Metrics**: 53% gross margin, 19.7% EBITDA margin, $12.3M cash on hand.

**【CEO Summary Section】**
- **2024 Financial Highlights**: Q4 revenue of $87.4M (+2% YoY), adjusted EBITDA of $17.2M (+44% YoY). Full-year revenue $339M, adjusted EBITDA $53M (+12% YoY). Cash flow from operations improved to $32M vs. $1M in 2023.
- **Global Workforce Strategy**: 30% of CBO clients now supported by global teams, targeting 60% in 2025. Q4 gross margin expanded to 53% (vs. 44.7% in 2023), driven by cost savings and offshore transitions.
- **nTrust Growth**: nTrust deals grew from 14 in 2022 to 24 in 2024. 75% of deals lost due to "no decision" rather than competition, highlighting market opportunity.
- **2025 Priorities**: 4% revenue growth, EBITDA margin expansion, 60 key CBO renewals over 24 months, and SaaS conversion of 1/3 of EHR customers.

**【CFO Financial Commentary】**
- **Cash Flow & Debt**: Free cash flow $15.5M in 2024 (vs. -$22M in 2023). Net debt reduced to $159M with leverage ratio 3x (from 4x in 2023). Q4 cash flow from ops $10.3M (+$23M YoY).
- **Margins & Efficiency**: Q4 adjusted EBITDA margin 19.7% (vs. 14% in 2023Q4). Capitalized software as % of revenue dropped to 4.3% (from 6.8% in 2023). 2025 guidance: revenue $345-360M, EBITDA $59-66M.
- **One-Time Items**: Q4 included $2M of nonrecurring Patient Care revenue and $1M of onetime labor savings. Sequential margin expansion tempered by annual conference and merit increases.

**【Q&A Key Takeaways】**
- **Bookings Visibility**: 2024Q4 bookings $14M (vs. $21M in Q3). 60% of 2025 bookings expected in H2. 60 key CBO renewals over 24 months with >100% retention rate to date.
- **Sales Cycle & Pricing**: 40% of bookings open and close in same quarter. No decision rate remains high but 50%+ win rate when decision made. SaaS conversions not material to near-term growth but improve predictability.
- **Competitive Position**: 75% of lost deals due to "no decision" vs. competition. nTrust cross-sell success (24 deals in 2024) and Viewgol growth offset EHR declines.
- **2025 Outlook**: Financial Health (+7% YoY) to drive growth, Patient Care (+low single digits) from new products. 200+ basis points margin expansion through global workforce and cost control.

Actual											0.61	0.39	0.67	0.55	0.64	0.75	0.59	0.7	0.81	0.59	0.57	0.61	0.58	0.4	-0.24	-2.92	-0.17	-0.34	-0.66	0.05	0.36	0.54	0.88
Forecast											0.5677	0.3766	0.5178	0.7007	0.5547	0.5547	0.6352	0.5703	0.6603	0.6555	0.6572	0.585	0.6993	0.5844	0.4197	-0.0596	-0.2988	-0.2798	-0.0906	0.0412	0.2913	0.2974	0.5905	0.637
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+7.45%	+3.56%	+29.39%	-21.51%	+15.38%	+35.21%	-7.12%	+22.74%	+22.67%	-9.99%	-13.27%	+4.27%	-17.06%	-31.55%	-157.18%	-4799.33%	+43.11%	-21.52%	-628.48%	+21.36%	+23.58%	+81.57%	+49.03%	0.00%

TBRG

TBRG fundamentals

TBRG Q4 2025 Earnings Preview

Earnings Call

You can ask Aime

TBRG

TBRG fundamentals

TBRG Q4 2025 Earnings Preview

Earnings Call

TBRG Earnings Call Summary for Q4/20254:30 PM on Mar 16, 2026

TBRG Earnings Call Summary for Q3/20258:30 AM on Nov 7, 2025

TBRG Earnings Call Summary for Q2/20258:30 AM on Aug 8, 2025

TBRG Earnings Call Summary for Q1/20254:30 PM on May 7, 2025

TBRG Earnings Call Summary for Q4/20244:30 PM on Mar 10, 2025

You can ask Aime